TP53 and serous adenocarcinoma: On the other hand, PDOX13 presented de novo serous carcinoma areas, as observed in the HE, characterized by an abnormal TP53, p16, and IMP2 stainings that were not observed in the initial tumor biopsy (Figure 3B,C).